glp 1 drugs and blood clots Ozempic & Clots: New Study Shows Lower Risk with GLP-1 Glucagon‐Like Peptide‐1 Receptor Agonists and
Description
GlobalData is the parent company of Pharmaceutical Technology
Ferry LH
10.1016/j.ijpharm.2024.123991
Learn more about the key factors that healthcare professionals consider, including BMI, weight loss attempts, health issues, psychological well-being, commitment to lifestyle changes, and more
It is not medication-specific medical advice
The cause is often attributed to diabetes
